Weight Loss
Tirzepatide is a medication known for its effects on fat loss, appetite suppression, metabolic regulation, and weight reduction. It has gained popularity among individuals focused on effective weight management and improving overall metabolic health. Tirzepatide is also widely prescribed under the brand name Mounjaro to help improve blood sugar control in adults with type 2 diabetes.
₦150,000.00 – ₦800,000.00₦120,000.00 – ₦640,000.00Specs
— 10mg per vial
— Reconstitute with 2ml BAC water
— Once weekly
— Weekly dose: 0.5 mL (2.5 mg) once weekly
— Duration: One 10 mg vial provides 4 weekly doses, equivalent to approximately 1 month
— Storage after reconstitution: Refrigerate at 2–8°C. Do not freeze
each vial ₦150,000.00₦120,000.00
To be used once weekly.
Draw 2 mL of BAC water and inject it into the vial. Slowly swirl the vial until the solution is completely dissolved.
After reconstitution, store the solution in the refrigerator and use within 28 days.
Nausea, vomiting, diarrhea, constipation, abdominal pain. These side effects tend to occur when starting the peptide or increasing your dose, especially as your body adjusts to the higher dose.
It targets 2 key hormone receptors:
—GLP-1 (Glucagon-like peptide-1): Increases insulin secretion, decreases glucagon secretion, slows stomach emptying and reduces appetite, helping to decrease calorie intake and support weight loss. This is the same mechanism targeted by semaglutide (Ozempic & Wegovy).
—GIP (Glucose-dependent Insulinotropic Polypeptide): Increases insulin secretion in a glucose-dependent manner and works alongside GLP-1 to regulate blood sugar, appetite and energy intake. Tirzepatide activates both GIP and GLP-1 receptors, giving it a dual mechanism of action.